Clinical trials
Adenocarcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 7 |
| 2013 | 1 |
| 2014 | 4 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 11 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
| Unknown status | 18 |
| Completed | 17 |
| Active, not recruiting | 9 |
| Not yet recruiting | 6 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 4 |
| Betta Pharmaceuticals Co., Ltd. | 4 |
| First Affiliated Hospital of Fujian Medical University | 4 |
| Fudan University | 4 |
| Ruijin Hospital | 4 |
| AstraZeneca | 3 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 3 |
| Peking University | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Abbott | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 74 |
| Stomach Neoplasms | 20 |
| Neoplasms | 14 |
| Prostatic Neoplasms | 13 |
| Carcinoma | 11 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Digestive System Neoplasms | 8 |
| Neoplasms by Site | 7 |
| Neoplasms, Glandular and Epithelial | 7 |
| Digestive System Diseases | 6 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.